Asenapine monotherapy in the acute treatment of both schizophrenia and bipolar I disorder

Delia Bishara1, David Taylor1,21Pharmacy Department, South London and Maudsley NHS Foundation Trust, Denmark Hill, London, UK; 2Division of Pharmaceutical Sciences, King’s College, London, UKAbstract: Asenapine is a new atypical antipsychotic agent currently under development for the t...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Delia Bishara, David Taylor
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2009
Materias:
Acceso en línea:https://doaj.org/article/a505025bb6854ca5b5e8c41bb5f7597a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!